Clinical Trials List
Protocol NumberC23-101
Active
2024-01-01 - 2028-12-31
Phase I
Not yet recruiting1
Recruiting1
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Yao-Yu Hsieh Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Principal Investigator
Co-Principal Investigator
- SHAUH-DER YEH
- 高冠鈞 Division of Hematology & Oncology
Co-Principal Investigator
- Chueh-Chuan Yen Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Yi-Ping Hung Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- 邱乃祈 Division of Radiology
- 唐振育 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
84 participants
-
Global
84 participants
